Hormone Replacement Therapy and Decreased Lung Cancer Survival
- 1 January 2006
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 24 (1) , 9-10
- https://doi.org/10.1200/jco.2005.04.2531
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Hormone Replacement Therapy Is Associated With Decreased Survival in Women With Lung CancerJournal of Clinical Oncology, 2006
- Progesterone Receptor in Non–Small Cell Lung Cancer—A Potent Prognostic Factor and Possible Target for Endocrine TherapyCancer Research, 2005
- Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cellsSteroids, 2005
- Regulation of Endogenous Gene Expression in Human Non–Small Cell Lung Cancer Cells by Estrogen Receptor LigandsCancer Research, 2005
- Combined Targeting of the Estrogen Receptor and the Epidermal Growth Factor Receptor in Non–Small Cell Lung Cancer Shows Enhanced Antiproliferative EffectsCancer Research, 2005
- Hormone Replacement Therapy and Lung Cancer RiskClinical Cancer Research, 2004
- The Aryl Hydrocarbon Receptor Mediates Degradation of Estrogen Receptor α through Activation of ProteasomesMolecular and Cellular Biology, 2003
- Expression, Function, and Clinical Implications of the Estrogen Receptor β in Human Lung CancersBiochemical and Biophysical Research Communications, 2001